Nitric Oxide Synthase in Breast Apocrine Metaplasia
Author Information
Author(s): W Tschugguell, W Knogler, K Czerwenka, M Mildner, W Weninger, R Zeillinger, JC Huber
Primary Institution: University of Vienna, School of Medicine
Hypothesis
Is the presence of endothelial calcium-dependent nitric oxide synthase associated with apocrine metaplastic change in benign breast disease?
Conclusion
The study found that endothelial calcium-dependent nitric oxide synthase is expressed in human breast apocrine metaplasia, which may be significant for its vascular effects in benign breast disease.
Supporting Evidence
- Endothelial calcium-dependent nitric oxide synthase was predominantly localized in apocrine metaplastic cells of fibrocystic disease.
- No immunoreactivity was observed in poorly differentiated infiltrating duct carcinoma cells.
- Immunohistochemical staining showed strong intensity in apocrine metaplastic cells.
Takeaway
This study looked at breast tissue samples and found a special protein that helps blood flow in certain benign breast changes, which might be important for understanding breast health.
Methodology
Immunohistochemistry was performed on frozen sections of 30 breast tissue samples to assess the distribution of nitric oxide synthase.
Limitations
The study did not explore the functional implications of eNOS expression in apocrine metaplasia or its potential role in malignant transformation.
Participant Demographics
The study included 30 breast tissue samples, with 21 from fibrocystic disease, 4 from fibroadenoma, and 5 from poorly differentiated duct carcinoma.
Want to read the original?
Access the complete publication on the publisher's website